Compare Abeona Therapeutics Inc (ABEO) vs CleanSpark Inc (CLSK) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs CleanSpark Inc — how do they compare? Abeona Therapeutics Inc trades at $6.74 (market cap $373.32M), while CleanSpark Inc trades at $12.03 (market cap $3.20B). The key difference: CleanSpark Inc is far larger — about 8.6× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, CleanSpark Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | CLSK | |
|---|---|---|
Market Cap | $373.32M | $3.20B |
Sector | Health | Technology |
52-Week High | $7.23 | $23.20 |
52-Week Low | $4.17 | $8.18 |
Enterprise Value | $228.22M | $4.06B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
CleanSpark (CLSK) trades at $13.51, up 7.05% today but facing bearish technical signals with recent earnings misses. The company reported strong revenue growth to $766M in 2025 but swung to a net loss margin of -67.66% in 2026. Analyst sentiment remains strongly bullish with 11 buy ratings and a $20.50 consensus target, though cash flow challenges persist with negative operating cash flow of $461M in 2025.
The stock presents a divergence between strong analyst support and challenging fundamentals. While Wall Street sees 100% upside potential, investors face execution risks from profitability challenges and volatile bitcoin mining economics. The technical setup suggests near-term pressure with the stock trading near support levels amid broader market uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About CleanSpark Inc
CleanSpark is a leading Bitcoin mining company that operates high-density data centers. It focuses on using sustainable energy to power its mining fleet and provides digital infrastructure for the blockchain ecosystem.
Read more on CLSK →
